Renoprotective effects of dulaglutide in patients with T2DM and CKD

被引：0
|
作者：
Charlotte M. Sorensen
Jens J. Holst
机构：
[1] University of Copenhagen,Department of Biomedical Sciences
来源：
Nature Reviews Nephrology | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The AWARD-7 trial shows that the glucagon-like peptide 1 (GLP1) receptor agonist dulaglutide, which is not cleared by the kidney, seems to be renoprotective, ameliorates albuminuria and slows estimated glomerular filtration rate decline in patients with type 2 diabetes mellitus and chronic kidney disease, without increasing the risk of hypoglycaemia.
引用
收藏
页码：659 / 660
页数：1
相关论文
共 50 条
  • [1] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Sorensen, Charlotte M.
    Holst, Jens J.
    NATURE REVIEWS NEPHROLOGY, 2018, 14 (11) : 659 - 660
  • [2] Risk of metformin use in patients with T2DM and advanced CKD
    Guntram Schernthaner
    Marie Helene Schernthaner-Reiter
    Nature Reviews Endocrinology, 2015, 11 : 697 - 699
  • [3] Efficacy by Baseline BMI with Once Weekly Dulaglutide in Chinese T2DM Patients
    Shi, Yongquan
    Zhang, Bin
    Wu, Haiya
    DIABETES, 2019, 68
  • [4] CV benefits of finerenone in T2DM and CKD
    Huynh K.
    Nature Reviews Cardiology, 2021, 18 (11) : 738 - 738
  • [5] Risk Factors for Incident T2DM in Patients with Prediabetes by CKD Status
    Hennessey, Kelly A.
    Alicic, Radica Z.
    Daratha, Kenn B.
    Jones, Cami
    Neumiller, Joshua J.
    Duru, O. Kenrik
    Nicholas, Susanne
    McPherson, Sterling M.
    Norris, Keith C.
    Tuttle, Katherine R.
    DIABETES, 2020, 69
  • [6] THERAPY Risk of metformin use in patients with T2DM and advanced CKD
    Schernthaner, Guntram
    Schernthaner-Reiter, Marie Helene
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (12) : 697 - 698
  • [7] T2DM/CKD genetic risk scores and the progression of diabetic kidney disease in T2DM subjects
    Galuska, David
    Pacal, Lukas
    Chalasova, Katarina
    Divacka, Petra
    Rehorova, Jitka
    Svojanovsky, Jan
    Hubacek, Jaroslav A.
    Lanska, Vera
    Kankova, Katerina
    GENE, 2024, 927
  • [8] Real-World Effectiveness, Adherence, and Persistence among Patients with T2DM Initiating Dulaglutide
    Mody, Reema
    Grabner, Michael
    Yu, Maria
    Turner, Ralph
    Kwan, Anita
    York, Whitney
    Lando, Laura Fernandez
    DIABETES, 2017, 66 : A355 - A355
  • [9] Metabolic effects of the Atkins' diet in patients with T2DM
    Sargrad, K
    Homko, C
    Mozzoli, M
    Boden, G
    DIABETES, 2003, 52 : A387 - A387
  • [10] T2DM MODIFIES THE RELATIONSHIP BETWEEN CAC AND ADVERSE KIDNEY OUTCOME IN PATIENTS WITH CKD
    Yun, Hae-Ryong
    Han, Seung Hyeok
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I573 - I574
12345